Xconomy National

Archives

by in

Entry	Author	Date	Location
RXi Sells Stock and Warrants, Cardiorobotics Raises $6.6M, ImmunoGen Dishes On New Drugs, & More Boston-Area Life Sciences News	Erin Kutz	03/04/11	Boston
Genzyme Rival Fails to Get FDA Approval	Ryan McBride	02/25/11	Boston
Genzyme Boss Henri Termeer Not Ready To Sell to Sanofi, Ride Into the Sunset, Sources Say	Ryan McBride	09/22/10	Boston
Xconomy Readers Set $20B Pricetag on Genzyme—Is That Too Rich for Sanofi-Aventis?	Ryan McBride	07/29/10	Boston
Genzyme in “Tough Spot” with Icahn Proxy Challenge—CEO Termeer Courting Key Shareholders	Ryan McBride	05/13/10	Boston
Cooking with the Genzyme Recipe: New Players Funding Rare Disease Drugs in Boston	Ryan McBride	04/12/10	Boston
Agreement Between Genzyme and San Diego Activist Shareholder Suggests Truce	Bruce V. Bigelow	01/07/10	San Diego
Shire Making Lemonade with Genzyme’s Lemons	Ryan McBride	12/15/09	Boston
Genzyme Resumes Shipments of Gaucher’s Drug from Allston Plant	Ryan McBride	12/01/09	Boston
Genzyme Competitor Lands Pfizer Deal	Ryan McBride	12/01/09	Boston
Genzyme’s Woes Piling Up as FDA Panel Says Data on Leukemia Drug are Lacking	Luke Timmerman	09/01/09	Boston
Another Genzyme Rival Advancing	Ryan McBride	09/01/09	Boston
Genzyme Rival Gets FDA Nod	Luke Timmerman	08/17/09	Boston
Shire’s Gaucher Drug Passes Key Trial, Putting More Heat on Genzyme During Shortage	Luke Timmerman	08/03/09	Boston
Genzyme Rival, Actelion, Seeks to Fill Void Created by Cerezyme Shortage	Luke Timmerman	07/09/09	Boston
Genzyme Offers Glimpse at Growth Engine, New Drugs for High Cholesterol, Gaucher’s	Luke Timmerman	05/07/09	Boston
Conn. Agency Pumps $515K into Helix Therapeutics	Ryan McBride	03/05/09	Boston
Arzeda, Maker of Designer Enzymes, Prepares to Leave UW Roots with New Leader and VC Bucks	Luke Timmerman	02/27/09	Seattle
Page 1 of 1